newsfilter
← Latest News
GlobeNewswire·

MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA

Q2 2026 Adjusted EBITDA1 of $0.9M, the Company’s strongest quarterly performance since 20192Positive net income in Q2 2026, compared with a net loss of $3.8M in Q2 2025OPEX decreased 44% in Q2 2026 versus Q2 2025Net